Plato 17
Payments companies reported to CMS as associated with Plato 17. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Plato 17, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Plato 17
These are the largest totals companies reported as associated with Plato 17. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kurt Reuland | Tyler, TX | Diagnostic Radiology | $705.79 |
| Daniel Sahlein | Carmel, IN | Vascular & Interventional Radiology | $648.68 |
| Diego Lozano | Lewistown, PA | Anesthesiology | $640.37 |
| Dan Nguyen | Colorado Springs, CO | Neurology (Psychiatry & Neurology) | $629.65 |
| Kaustubh Limaye | Indianapolis, IN | Neurology (Psychiatry & Neurology) | $569.79 |
| Huy Nguyen | Plano, TX | Neurological Surgery | $515.53 |
| Rahul Shah | Shreveport, LA | Neurocritical Care | $410.61 |
| Amir Khan | Fresno, CA | Neurology (Psychiatry & Neurology) | $387.62 |
| Matthew Fiesta | Fort Worth, TX | Diagnostic Radiology | $382.54 |
| Haydn Hoffman | Memphis, TN | Neurological Surgery | $350.26 |
Prescribed Plato 17?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.